Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Mehrdad Hefazi, MD, Reona Sakemura, MD PhD, Saad S. Kenderian, MD, Mrinal M Patnaik, MDMBBS, William J Hogan, MB, BCh, Mark Litzow, MD, Hemang Yadav, MBBS

Blood (2019) 134 (Supplement_1): 4500.

https://doi.org/10.1182/blood-2019-132133

Published: 2019

Journal Articles

Safety Profile of Bone Marrow Aspiration and Biopsies Performed By the Hospitalist Procedure Service at an Academic Center: An Observational Study

Jennifer U Obasi, MD, Adrian P Umpierrez De Reguero, MD

Blood (2019) 134 (Supplement_1): 5848.

https://doi.org/10.1182/blood-2019-121444

Published: 2019

Journal Articles

In-Hospital Outcomes of Neutropenic Fever: A Study Using the National Inpatient Sample, Years 2009-2013

Urshila Durani, MD MPH, Ronald S. Go, MD

Blood (2016) 128 (22): 4762.

https://doi.org/10.1182/blood.V128.22.4762.4762

Published: 2016

Journal Articles

Safety and Efficacy Of Ferumoxytol For The Episodic Treatment Of Iron Deficiency Anemia In Patients With a History Of Unsatisfactory Oral Iron Therapy: Results Of a Phase III Open-Label, Six Month Extension Study

Saroj Vadhan-Raj, MD, Naomi V Dahl, Pharm.D., Gloria Lau, MSc, Kristine Bernard, Zhu Li, PhD, Pallabi De, PhD, Lee F. Allen, MD, PhD, William Strauss, M.D., F.A.C.C.

Blood (2013) 122 (21): 2201.

https://doi.org/10.1182/blood.V122.21.2201.2201

Published: 2013

Journal Articles

First In Europe International Cooperation For Clinical Use Of Wharton Jelly-Derived Mesenchymal Stem Cells

Dominika Gladysz, Katarzyna Pawelec, MD.PhD, Iwona Czaplicka, Magdalena Murzyn, Artur Olkowicz, Tomasz Oldak, Jakub Baran, Dariusz Boruczkowski, MD, PhD

Blood (2013) 122 (21): 2035.

https://doi.org/10.1182/blood.V122.21.2035.2035

Published: 2013

Journal Articles

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Alan Tinmouth, MD, FRCPC, Victor S. Blanchette, Ramachandran Devaraj, Bruce Ritchie, David Barnes, Gigi van den Hoef

Blood (2009) 114 (22): 4190.

https://doi.org/10.1182/blood.V114.22.4190.4190

Published: 2009

Journal Articles

Complications of Hyperleukocytosis and Leukapheresis in Pediatric Acute Leukemias.

Oussama Abla, MD, M. F. Khanani, MD, J. K. Hitzler, MD, L. Sung, MD, D. Geary, MD, M. Abdelhaleem, MD, S. Weitzman, MD, A. Naqvi, MD

Blood (2004) 104 (11): 1963.

https://doi.org/10.1182/blood.V104.11.1963.1963

Published: 2004

NARROW

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Safety Profile of Bone Marrow Aspiration and Biopsies Performed By the Hospitalist Procedure Service at an Academic Center: An Observational Study

In-Hospital Outcomes of Neutropenic Fever: A Study Using the National Inpatient Sample, Years 2009-2013

Safety and Efficacy Of Ferumoxytol For The Episodic Treatment Of Iron Deficiency Anemia In Patients With a History Of Unsatisfactory Oral Iron Therapy: Results Of a Phase III Open-Label, Six Month Extension Study

First In Europe International Cooperation For Clinical Use Of Wharton Jelly-Derived Mesenchymal Stem Cells

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Complications of Hyperleukocytosis and Leukapheresis in Pediatric Acute Leukemias.

Email alerts

ASH Publications

American Society of Hematology

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Safety Profile of Bone Marrow Aspiration and Biopsies Performed By the Hospitalist Procedure Service at an Academic Center: An Observational Study

In-Hospital Outcomes of Neutropenic Fever: A Study Using the National Inpatient Sample, Years 2009-2013

Safety and Efficacy Of Ferumoxytol For The Episodic Treatment Of Iron Deficiency Anemia In Patients With a History Of Unsatisfactory Oral Iron Therapy: Results Of a Phase III Open-Label, Six Month Extension Study

First In Europe International Cooperation For Clinical Use Of Wharton Jelly-Derived Mesenchymal Stem Cells

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Complications of Hyperleukocytosis and Leukapheresis in Pediatric Acute Leukemias.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only